Guggenheim Capital’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $976K | Sell |
4,303
-858
| -17% | -$153K | 0.01% | 1034 |
|
|
2026
Q1 | $890K | Sell |
5,161
-77
| -1% | -$14.3K | 0.01% | 1028 |
|
|
2025
Q4 | $1.04M | Sell |
5,238
-815
| -13% | -$148K | 0.01% | 929 |
|
|
2025
Q3 | $947K | Sell |
6,053
-231
| -4% | -$36.7K | 0.01% | 942 |
|
|
2025
Q2 | $953K | Sell |
6,284
-144
| -2% | -$19.2K | 0.01% | 900 |
|
|
2025
Q1 | $968K | Sell |
6,428
-1,825
| -22% | -$306K | 0.01% | 888 |
|
|
2024
Q4 | $1.52M | Buy |
8,253
+725
| +10% | +$140K | 0.01% | 745 |
|
|
2024
Q3 | $1.48M | Sell |
7,528
-174
| -2% | -$36.2K | 0.01% | 942 |
|
|
2024
Q2 | $1.59M | Sell |
7,702
-1,086
| -12% | -$246K | 0.01% | 897 |
|
|
2024
Q1 | $2.38M | Buy |
8,788
+125
| +1% | +$29.9K | 0.02% | 831 |
|
|
2023
Q4 | $2.05M | Sell |
8,663
-712
| -8% | -$140K | 0.02% | 841 |
|
|
2023
Q3 | $1.84M | Sell |
9,375
-177
| -2% | -$36.3K | 0.02% | 838 |
|
|
2023
Q2 | $2.01M | Sell |
9,552
-786
| -8% | -$156K | 0.02% | 854 |
|
|
2023
Q1 | $2.09M | Buy |
10,338
+1,394
| +16% | +$316K | 0.02% | 828 |
|
|
2022
Q4 | $1.95M | Sell |
8,944
-4,211
| -32% | -$920K | 0.02% | 867 |
|
|
2022
Q3 | $2.59M | Sell |
13,155
-256
| -2% | -$55.3K | 0.02% | 745 |
|
|
2022
Q2 | $2.87M | Sell |
13,411
-1,504
| -10% | -$368K | 0.02% | 756 |
|
|
2022
Q1 | $4.24M | Sell |
14,915
-3,807
| -20% | -$1.17M | 0.03% | 714 |
|
|
2021
Q4 | $7.05M | Sell |
18,722
-3,030
| -14% | -$1.18M | 0.04% | 548 |
|
|
2021
Q3 | $8.98M | Buy |
21,752
+1,619
| +8% | +$672K | 0.05% | 425 |
|
|
2021
Q2 | $7.45M | Buy |
20,133
+7,880
| +64% | +$2.63M | 0.04% | 506 |
|
|
2021
Q1 | $3.55M | Buy |
12,253
+320
| +3% | +$89K | 0.02% | 770 |
|
|
2020
Q4 | $2.98M | Buy |
11,933
+5,050
| +73% | +$1.2M | 0.02% | 793 |
|
|
2020
Q3 | $1.56M | Buy |
6,883
+273
| +4% | +$56.7K | 0.01% | 999 |
|
|
2020
Q2 | $1.15M | Buy |
6,610
+278
| +4% | +$44.4K | 0.01% | 1124 |
|
|
2020
Q1 | $799K | Sell |
6,332
-679
| -10% | -$102K | 0.01% | 1188 |
|
|
2019
Q4 | $1.07M | Buy |
7,011
+986
| +16% | +$137K | 0.01% | 1299 |
|
|
2019
Q3 | $797K | Buy |
6,025
+353
| +6% | +$47.3K | 0.01% | 1419 |
|
|
2019
Q2 | $805K | Sell |
5,672
-249
| -4% | -$33.8K | 0.01% | 1447 |
|
|
2019
Q1 | $860K | Buy |
5,921
+1,499
| +34% | +$197K | 0.01% | 1455 |
|
|
2018
Q4 | $500K | Sell |
4,422
-59,483
| -93% | -$7.45M | ﹤0.01% | 1677 |
|
|
2018
Q3 | $8.6M | Sell |
63,905
-12,837
| -17% | -$1.58M | 0.06% | 421 |
|
|
2018
Q2 | $8.61M | Sell |
76,742
-62,969
| -45% | -$6.81M | 0.06% | 392 |
|
|
2018
Q1 | $14.9M | Buy |
139,711
+20,697
| +17% | +$2.23M | 0.04% | 570 |
|
|
2017
Q4 | $13M | Buy |
119,014
+65,313
| +122% | +$7.11M | 0.03% | 609 |
|
|
2017
Q3 | $5.8M | Buy |
53,701
+3,263
| +6% | +$335K | 0.01% | 973 |
|
|
2017
Q2 | $5.1M | Sell |
50,438
-4,646
| -8% | -$428K | 0.01% | 1006 |
|
|
2017
Q1 | $4.96M | Sell |
55,084
-21,586
| -28% | -$1.83M | 0.01% | 1027 |
|
|
2016
Q4 | $5.84M | Sell |
76,670
-57,177
| -43% | -$4.34M | 0.02% | 908 |
|
|
2016
Q3 | $11.2M | Sell |
133,847
-3,464
| -3% | -$290K | 0.03% | 625 |
|
|
2016
Q2 | $11.3M | Sell |
137,311
-15,562
| -10% | -$1.28M | 0.04% | 631 |
|
|
2016
Q1 | $11.6M | Sell |
152,873
-30,785
| -17% | -$2.28M | 0.04% | 659 |
|
|
2015
Q4 | $14.8M | Sell |
183,658
-54,771
| -23% | -$3.95M | 0.04% | 628 |
|
|
2015
Q3 | $15.1M | Buy |
238,429
+2,370
| +1% | +$170K | 0.05% | 615 |
|
|
2015
Q2 | $16.6M | Buy |
236,059
+22,496
| +11% | +$1.66M | 0.04% | 659 |
|
|
2015
Q1 | $16.9M | Buy |
213,563
+7,016
| +3% | +$518K | 0.04% | 668 |
|
|
2014
Q4 | $13.1M | Sell |
206,547
-22,284
| -10% | -$1.4M | 0.03% | 736 |
|
|
2014
Q3 | $13.7M | Sell |
228,831
-6,171
| -3% | -$353K | 0.03% | 778 |
|
|
2014
Q2 | $12.6M | Sell |
235,002
-27,247
| -10% | -$1.5M | 0.03% | 787 |
|
|
2014
Q1 | $15.8M | Buy |
262,249
+30,769
| +13% | +$1.79M | 0.05% | 719 |
|
|
2013
Q4 | $12.3M | Buy |
231,480
+5,763
| +3% | +$289K | 0.04% | 765 |
|
|
2013
Q3 | $10.4M | Buy |
225,717
+26,989
| +14% | +$1.24M | 0.04% | 826 |
|
|
2013
Q2 | $8.15M | Buy |
+198,728
| New | +$8.51M | 0.03% | 857 |
|
Other funds holding CRL
AI
Guggenheim Capital's CRL Position: Q2 2026 in Review
Guggenheim Capital reduced its Charles River Laboratories (CRL) stake by 17% in Q2 2026, selling an estimated $153K and leaving 4,303 shares worth $976K. The position accounts for 0.01% of the portfolio, ranked #1034.
Guggenheim Capital first reported a position in CRL in Q2 2013 and has held it in 53 quarters since. The position peaked at $16.9M in Q1 2015. 568 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Guggenheim Capital held 4,303 shares of Charles River Laboratories worth $976K as of Q2 2026.
- Guggenheim Capital sold 858 Charles River Laboratories shares in Q2 2026, an estimated $153K.
- Charles River Laboratories made up 0.01% of Guggenheim Capital's portfolio in Q2 2026, its #1034 holding.
- Guggenheim Capital first reported a position in Charles River Laboratories in Q2 2013 and has held it in 53 quarters since.
- Guggenheim Capital's Charles River Laboratories position peaked at $16.9M in Q1 2015.
- 568 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.